ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2016

Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors.

Hyeon-Seok Eom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.